UA95103U - METHOD OF TREATMENT OF PLACENTARIAL DYSFUNCTION - Google Patents
METHOD OF TREATMENT OF PLACENTARIAL DYSFUNCTIONInfo
- Publication number
- UA95103U UA95103U UAU201407167U UAU201407167U UA95103U UA 95103 U UA95103 U UA 95103U UA U201407167 U UAU201407167 U UA U201407167U UA U201407167 U UAU201407167 U UA U201407167U UA 95103 U UA95103 U UA 95103U
- Authority
- UA
- Ukraine
- Prior art keywords
- placental
- dysfunction
- fetal
- placentarial
- treatment
- Prior art date
Links
- 230000004064 dysfunction Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 230000001605 fetal effect Effects 0.000 abstract 4
- 230000003169 placental effect Effects 0.000 abstract 2
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 abstract 1
- 102100021809 Chorionic somatomammotropin hormone 1 Human genes 0.000 abstract 1
- 102000013469 Placental Hormones Human genes 0.000 abstract 1
- 108010065857 Placental Hormones Proteins 0.000 abstract 1
- 108010003044 Placental Lactogen Proteins 0.000 abstract 1
- 239000000381 Placental Lactogen Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 abstract 1
- 229960001348 estriol Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 230000001771 impaired effect Effects 0.000 abstract 1
- 235000019136 lipoic acid Nutrition 0.000 abstract 1
- 239000002281 placental hormone Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 229960002663 thioctic acid Drugs 0.000 abstract 1
- 230000036266 weeks of gestation Effects 0.000 abstract 1
- -1 α-lipoic acid ethylenediamine salts Chemical class 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
В способі лікування плацентарної дисфункції шляхом використання комплексної терапії попередньо визначають рівень вільного естріолу, плацентарного лактогену, показники стану плода та розміри плода, і за умови порушення синтезу гормонів та зменшення розмірів плода призначають препарати α-ліпоєвої кислоти етилендіамінової солі та препарати α-аміно-d-гуанідиновалеріанової кислоти впродовж 10-14 днів під контролем гормонів плаценти та розмірів плода у вагітних із плацентарною дисфункцією у терміні вагітності 28-34 тижні.In the method of treating placental dysfunction by the use of complex therapy, pre-determine the level of free estriol, placental lactogen, indicators of fetal status and fetal size, and in the case of impaired hormone synthesis and reduction of fetal size, prescribe α-lipoic acid ethylenediamine salts and d-α preparations -guanidinoleric acid for 10-14 days under the control of placental hormones and fetal size in pregnant women with placental dysfunction at 28-34 weeks of gestation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201407167U UA95103U (en) | 2014-06-25 | 2014-06-25 | METHOD OF TREATMENT OF PLACENTARIAL DYSFUNCTION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201407167U UA95103U (en) | 2014-06-25 | 2014-06-25 | METHOD OF TREATMENT OF PLACENTARIAL DYSFUNCTION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA95103U true UA95103U (en) | 2014-12-10 |
Family
ID=52681292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201407167U UA95103U (en) | 2014-06-25 | 2014-06-25 | METHOD OF TREATMENT OF PLACENTARIAL DYSFUNCTION |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA95103U (en) |
-
2014
- 2014-06-25 UA UAU201407167U patent/UA95103U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Imanieh et al. | Oxytocin has therapeutic effects on cancer, a hypothesis | |
| PH12017500070A1 (en) | Methods of treating cancer using tigit inhibitors and anti-cancer agents | |
| BR112016017700A2 (en) | method for treating a cancer in an individual, drug, kit, method, use or kit, and, method, drug or kit | |
| CL2015002708A1 (en) | Heterocyclic compounds and their uses. | |
| MX2016015181A (en) | Combination of an anti-ccr4 antibody and a 4-1bb agonist for treating cancer. | |
| EP2968967A4 (en) | CONTROL SYSTEM AND FLEXIBLE COILS FOR TREATMENT ADMINISTRATION, FOR EXAMPLE FOR THE TREATMENT OF CANCER | |
| NZ774222A (en) | Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof | |
| MX2018011705A (en) | Steroid hormone pharmaceutical composition. | |
| PH12017500933A1 (en) | Sublingual administration of riluzole | |
| MX2017007707A (en) | Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer. | |
| PH12017500934A1 (en) | Sublingual formulation of riluzole | |
| PH12017501493A1 (en) | Methods of treating infertility | |
| MX364985B (en) | Imidazolyl progesterone antagonists. | |
| MX2017000306A (en) | Methods for treating hypotension. | |
| MY196276A (en) | Isoindole Compounds | |
| MX2015008726A (en) | Intracellular phenotypic screening. | |
| UA95103U (en) | METHOD OF TREATMENT OF PLACENTARIAL DYSFUNCTION | |
| NZ719745A (en) | Soluble fc gamma receptor for treatment of autoimmune bullous diseases | |
| BR112016014099A2 (en) | wound treatment method | |
| MX2020005454A (en) | Improved treatment of cancer. | |
| MX2020006368A (en) | Use of combined treatment of pd-1 antibody and apatinib for treating triple negative breast cancer. | |
| PH12018500339A1 (en) | Lysobactin for use in the treatment of bovine mastitis | |
| UA85636U (en) | Method for treatment of threatened premature birth in pregnant women with multiple pregnancy with spaskurpeldrug | |
| UA76151U (en) | METHOD OF PREVENTION OF PLACENTENTIAL DYSFUNCTION IN PREGNANT PREGNANT PREGNANCY | |
| AU2015242879A8 (en) | Melatonin secretion regulator, and method for regulating melatonin secretion |